RxREVU is the industry leader in Prescription Decision Support on a mission to improve healthcare by providing accurate, patient-specific coverage and cost data at the point-of-care.
RxRevu's solutions help physicians quickly and easily find affordable care options specific to a patient's health and financial needs.
RxREVU was founded in 2013 by Carm Huntress, Peregrin Marshall, and Daniel Robert Caron. The company is headquartered in Denver, Colorado.
RxRevu's solutions help physicians quickly and easily find affordable care options specific to a patient's health and financial needs. With comprehensive, clinically-relevant information at their fingertips, physicians can make more informed, consistent, and frictionless care decisions.
RxRevu has developed SwiftRx, an EHR-embedded technology that allows clinicians to view prior authorizations and real-time, patient-specific cost information and drug options that are aligned with formulary and benefit data.
RxRevu's solutions also enable health systems to manage and measure clinician's performance and variability. It has already reached 2,000 hospitals in less than two years.
RxREVU is backed by JAZZ Venture Partners, University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health and others. The company raised $7M in a Series B round on Jan 27, 2021. This brings RxREVU's total funding to $28.2M to date.